<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34747551</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>Acute flaccid myelitis and Guillain-Barr&#xe9; syndrome in children: A comparative study with evaluation of diagnostic criteria.</ArticleTitle><Pagination><StartPage>593</StartPage><EndPage>604</EndPage><MedlinePgn>593-604</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.15170</ELocationID><Abstract><AbstractText Label="BACKGROUND AND PURPOSE">Differentiation between acute flaccid myelitis (AFM) and Guillain-Barr&#xe9; syndrome (GBS) can be difficult, particularly in children. Our objective was to improve the diagnostic accuracy by giving recommendations based on a comparison of clinical features and diagnostic criteria in children with AFM or GBS.</AbstractText><AbstractText Label="METHODS">A cohort of 26 children with AFM associated with enterovirus D68 was compared to a cohort of 156 children with GBS. The specificity of the Brighton criteria, used for GBS diagnosis, was evaluated in the AFM cohort and the specificity of the Centers for Disease Control and Prevention (CDC) AFM diagnostic criteria in the GBS cohort.</AbstractText><AbstractText Label="RESULTS">Children with AFM compared to those with GBS had a shorter interval between onset of weakness and nadir (3 vs. 8&#xa0;days, p&#xa0;&lt;&#xa0;0.001), more often had asymmetric limb weakness (58% vs. 0%, p&#xa0;&lt;&#xa0;0.001), and less frequently had sensory deficits (0% vs. 40%, p&#xa0;&lt;&#xa0;0.001). In AFM, cerebrospinal fluid leukocyte counts were higher, whereas protein concentrations were lower. Spinal cord lesions on magnetic resonance imaging were only found in AFM patients. No GBS case fulfilled CDC criteria for definite AFM. Of the AFM cases, 8% fulfilled the Brighton criteria for GBS, when omitting the criterion of excluding an alternate diagnosis.</AbstractText><AbstractText Label="CONCLUSIONS">Despite the overlap in clinical presentation, we found distinctive early clinical and diagnostic characteristics for differentiating AFM from GBS in children. Diagnostic criteria for AFM and GBS usually perform well, but some AFM cases may fulfill clinical diagnostic criteria for GBS. This underlines the need to perform diagnostic tests early to exclude AFM in children suspected of atypical GBS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Helfferich</LastName><ForeName>Jelte</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-4022-6162</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roodbol</LastName><ForeName>Joyce</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology and Pediatric Neurology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Wit</LastName><ForeName>Marie-Claire</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Pediatric Neurology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouwer</LastName><ForeName>Oebele F</ForeName><Initials>OF</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Bart C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>2016 Enterovirus D68 Acute Flaccid Myelitis Working Group and the Dutch Pediatric GBS Study Group</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="Y">Central Nervous System Viral Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020275" MajorTopicYN="Y">Guillain-Barre Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="Y">Myelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009468" MajorTopicYN="Y">Neuromuscular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brighton criteria</Keyword><Keyword MajorTopicYN="N">Guillain-Barr&#xe9; syndrome</Keyword><Keyword MajorTopicYN="N">acute flaccid myelitis</Keyword></KeywordList><CoiStatement>M.C.d.W. has received honoraria paid to her institution by Novartis for serving on a steering committee and presenting at a conference, and has received research funding from the Epilepsiefonds (Dutch Epilepsy Foundation), Hersenstichting, and Sophia Foundation. B.C.J. has received funding for travel from Baxter International, and has received research funding from the Netherlands Organization for Health Research and Development, Erasmus MC, Prinses Beatrix Spierfonds, Stichting Spieren voor Spieren, CSL&#x2010;Behring, Grifols, Annexon, Hansa Biopharma, and the GBS&#x2010;CIDP Foundation International. None of the other authors has any conflict of interest to disclose.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Aberle</LastName><ForeName>Stephan W</ForeName><Initials>SW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Popow-Kraupp</LastName><ForeName>Theresia</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nikolaeva-Glomb</LastName><ForeName>Lubomira</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rainetova</LastName><ForeName>Petra</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Midgley</LastName><ForeName>Sofie</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Fischer</LastName><ForeName>Thea K&#xf8;lsen</ForeName><Initials>TK</Initials></Investigator><Investigator ValidYN="Y"><LastName>Simonlatser</LastName><ForeName>Grethel</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Savolainen-Kopra</LastName><ForeName>Carita</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lina</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schuffenecker</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Aubart</LastName><ForeName>Melodie</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Gitiaux</LastName><ForeName>Cyril</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Antona</LastName><ForeName>Denise</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eis-H&#xfc;binger</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Buderus</LastName><ForeName>Stephan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Panning</LastName><ForeName>Marcus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nowotny</LastName><ForeName>Markus</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kiechle</LastName><ForeName>Lisa</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>B&#xf6;ttcher</LastName><ForeName>Sindy</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tak&#xe1;cs</LastName><ForeName>M&#xe1;ria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Farkas</LastName><ForeName>&#xc1;gnes</ForeName><Initials>&#xc1;</Initials></Investigator><Investigator ValidYN="Y"><LastName>L&#xf6;ve</LastName><ForeName>Arthur</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Baldanti</LastName><ForeName>Fausto</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Capobianchi</LastName><ForeName>Maria Rosaria</ForeName><Initials>MR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Valli</LastName><ForeName>Maria Beatrice</ForeName><Initials>MB</Initials></Investigator><Investigator ValidYN="Y"><LastName>Esposito</LastName><ForeName>Susanna</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pariani</LastName><ForeName>Elena</ForeName><Initials>E</Initials></Investigator><Investigator ValidYN="Y"><LastName>Binda</LastName><ForeName>Sandro</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Neuteboom</LastName><ForeName>Rinze</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Pas</LastName><ForeName>Suzan</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Benschop</LastName><ForeName>Kimberley</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Meijer</LastName><ForeName>Adam</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nordb&#xf8;</LastName><ForeName>Svein Arne</ForeName><Initials>SA</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hafstr&#xf8;m</LastName><ForeName>Maria</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dudman</LastName><ForeName>Susanne Gjeruldsen</ForeName><Initials>SG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Viekilde Pfeiffer</LastName><ForeName>Helle Cecilie</ForeName><Initials>HC</Initials></Investigator><Investigator ValidYN="Y"><LastName>Guiomar</LastName><ForeName>Raquel</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Palminha</LastName><ForeName>Paula</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Costa</LastName><ForeName>In&#xea;s</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dias</LastName><ForeName>Andrea Sofia</ForeName><Initials>AS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tecu</LastName><ForeName>Cristina</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cherciu</LastName><ForeName>Carmen Maria</ForeName><Initials>CM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lazarevic</LastName><ForeName>Ivana</ForeName><Initials>I</Initials></Investigator><Investigator ValidYN="Y"><LastName>Filipovi&#x107;-Vignjevi&#x107;</LastName><ForeName>Svetlana</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Berginc</LastName><ForeName>Natasa</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Marg&#xfc;ello</LastName><ForeName>M&#xf3;nica Gozalo</ForeName><Initials>MG</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cabrerizo</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garc&#xed;a I&#xf1;iguez</LastName><ForeName>Juan Pablo</ForeName><Initials>JP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Castro</LastName><ForeName>Sonia Perez</ForeName><Initials>SP</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rodrigo</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ant&#xf3;n</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Garcia</LastName><ForeName>N&#xfa;ria Rabella</ForeName><Initials>NR</Initials></Investigator><Investigator ValidYN="Y"><LastName>Dyrdak</LastName><ForeName>Robert</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Albert</LastName><ForeName>Jan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kramer</LastName><ForeName>Rolf</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stacpoole</LastName><ForeName>Sybil</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Thomas</LastName><ForeName>Rhys</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>O'Flaherty</LastName><ForeName>Niamh</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Drew</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Templeton</LastName><ForeName>Kate</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDougall</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eunson</LastName><ForeName>Paul</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Chinchankar</LastName><ForeName>Nandita</ForeName><Initials>N</Initials></Investigator><Investigator ValidYN="Y"><LastName>Shetty</LastName><ForeName>Jay</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moore</LastName><ForeName>Catherine</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williams</LastName><ForeName>Christopher</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Knoester</LastName><ForeName>Marjolein</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Poelman</LastName><ForeName>Randy</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>van Leer-Buter</LastName><ForeName>Coretta</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niesters</LastName><ForeName>Bert</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Engelen</LastName><ForeName>Marc</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Erasmus</LastName><ForeName>Corrie E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Geleijns</LastName><ForeName>Karin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Kotsopoulos</LastName><ForeName>Irene A W</ForeName><Initials>IAW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Nicolai</LastName><ForeName>Joost</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niermeijer</LastName><ForeName>Jikke-Mien F</ForeName><Initials>JF</Initials></Investigator><Investigator ValidYN="Y"><LastName>Niks</LastName><ForeName>Erik H</ForeName><Initials>EH</Initials></Investigator><Investigator ValidYN="Y"><LastName>Samijn</LastName><ForeName>Johnny P A</ForeName><Initials>JPA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>8</Day><Hour>8</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34747551</ArticleId><ArticleId IdType="pmc">PMC9299116</ArticleId><ArticleId IdType="doi">10.1111/ene.15170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Williams CJ, Thomas RH, Pickersgill TP, et al. Cluster of atypical adult Guillain&#x2010;Barre syndrome temporally associated with neurological illness due to EV&#x2010;D68 in children, South Wales, United Kingdom, October 2015 to January 2016. Euro Surveill Bull Eur Mal Transm Eur Commun Dis Bull. 2016;21(4):26&#x2010;32. doi:10.2807/1560-7917.ES.2016.21.4.30119</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.4.30119</ArticleId><ArticleId IdType="pubmed">26848143</ArticleId></ArticleIdList></Reference><Reference><Citation>CSTE . Revision to the standardized case definition, case classification, and Public Health Reporting for Acute Flaccid Myelitis.</Citation></Reference><Reference><Citation>Elrick MJ, Gordon&#x2010;Lipkin E, Crawford TO, et al. Clinical subpopulations in a sample of North American Children diagnosed with acute flaccid myelitis, 2012&#x2013;2016. JAMA Pediatr. 2019;173(2):134&#x2010;139. doi:10.1001/jamapediatrics.2018.4890</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2018.4890</ArticleId><ArticleId IdType="pmc">PMC6439600</ArticleId><ArticleId IdType="pubmed">30500056</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer R, Lina B, Shetty J. Acute flaccid myelitis caused by enterovirus D68: Case definitions for use in clinical practice. Eur J Paediatr Neurol EJPN Eur Paediatr Neurol Soc. 2019;23(2):235&#x2010;239. doi:10.1016/j.ejpn.2019.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2019.01.001</ArticleId><ArticleId IdType="pubmed">30670331</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Kohl KS, Gidudu J, et al. Guillain&#x2010;Barr&#xe9; syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599&#x2010;612. doi:10.1016/j.vaccine.2010.06.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.06.003</ArticleId><ArticleId IdType="pubmed">20600491</ArticleId></ArticleIdList></Reference><Reference><Citation>Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain&#x2010;Barre syndrome. Ann Neurol. 1990;27(Suppl):S21&#x2010;S24. doi:10.1002/ana.410270707</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410270707</ArticleId><ArticleId IdType="pubmed">2194422</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoester M, Helfferich J, Poelman R, et al. Twenty&#x2010;nine cases of enterovirus&#x2010;D68&#x2010;associated acute flaccid myelitis in Europe 2016: a case series and epidemiologic overview. Pediatr Infect Dis J. 2019;38(1):16&#x2010;21. doi:10.1097/INF.0000000000002188</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002188</ArticleId><ArticleId IdType="pmc">PMC6296836</ArticleId><ArticleId IdType="pubmed">30234793</ArticleId></ArticleIdList></Reference><Reference><Citation>CSTE . Acute Flaccid Myelitis (AFM) 2018 Case Definition.</Citation></Reference><Reference><Citation>Roodbol J, de Wit M&#x2010;CY, van den Berg B, et al. Diagnosis of Guillain&#x2010;Barr&#xe9; syndrome in children and validation of the Brighton criteria. J Neurol. 2017;264(5):856&#x2010;861. doi:10.1007/s00415-017-8429-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-017-8429-8</ArticleId><ArticleId IdType="pmc">PMC5413522</ArticleId><ArticleId IdType="pubmed">28251358</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs BC, van den Berg B, Verboon C, et al. International Guillain&#x2010;Barr&#xe9; Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain&#x2010;Barr&#xe9; syndrome. J Peripher Nerv Syst. 2017;22(2):68&#x2010;76. doi:10.1111/jns.12209</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12209</ArticleId><ArticleId IdType="pubmed">28406555</ArticleId></ArticleIdList></Reference><Reference><Citation>Roodbol J, de Wit MCY, Walgaard C, de Hoog M, Catsman&#x2010;Berrevoets CE, Jacobs BC. Recognizing Guillain&#x2010;Barre syndrome in preschool children. Neurology. 2011;76(9):807&#x2010;810. doi:10.1212/WNL.0b013e31820e7b62</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31820e7b62</ArticleId><ArticleId IdType="pubmed">21357832</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain&#x2010;Barr&#xe9; syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain&#x2010;Barr&#xe9; Syndrome Trial Group. Ann Neurol. 1998;44(5):780&#x2010;788. doi:10.1002/ana.410440512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440512</ArticleId><ArticleId IdType="pubmed">9818934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RA, Newsom&#x2010;Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet (London, England). 1978;2(8093):750&#x2010;753. doi:10.1016/s0140-6736(78)92644-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(78)92644-2</ArticleId><ArticleId IdType="pubmed">80682</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlmann V, Roodbol J, van Leeuwen N, et al. Validated age&#x2010;specific reference values for CSF total protein levels in children. Eur J Paediatr Neurol EJPN Eur Paediatr Neurol Soc. 2017;21(4):654&#x2010;660. doi:10.1016/j.ejpn.2017.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2017.03.006</ArticleId><ArticleId IdType="pubmed">28461111</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Schreiner TL, Van HK, et al. Acute flaccid myelitis: a clinical review of US cases 2012&#x2013;2015. Ann Neurol. 2016;80(3):326&#x2010;338. doi:10.1002/ana.24730</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24730</ArticleId><ArticleId IdType="pmc">PMC5098271</ArticleId><ArticleId IdType="pubmed">27422805</ArticleId></ArticleIdList></Reference><Reference><Citation>Chong PF, Kira R, Mori H, et al. Clinical features of acute flaccid myelitis temporally associated with an enterovirus D68 outbreak: results of a Nationwide Survey of Acute Flaccid Paralysis in Japan, August&#x2010;December 2015. Clin Infect Dis. 2017;66(5):653&#x2010;664. doi:10.1093/cid/cix860</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix860</ArticleId><ArticleId IdType="pmc">PMC5850449</ArticleId><ArticleId IdType="pubmed">29028962</ArticleId></ArticleIdList></Reference><Reference><Citation>Yea C, Bitnun A, Robinson J, et al. Longitudinal outcomes in the 2014 acute flaccid paralysis cluster in Canada. J Child Neurol. 2017;32(3):301&#x2010;307. doi:10.1177/0883073816680770</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073816680770</ArticleId><ArticleId IdType="pubmed">28193112</ArticleId></ArticleIdList></Reference><Reference><Citation>Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood Guillain&#x2010;Barre syndrome: a prospective multicentre study. Neuropediatrics. 2007;38(1):10&#x2010;17. doi:10.1055/s-2007-981686</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-981686</ArticleId><ArticleId IdType="pubmed">17607598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw DY, Jones HRJ. Guillain&#x2010;Barre syndrome in children: clinical course, electrodiagnosis, and prognosis. Muscle Nerve. 1992;15(4):500&#x2010;506. doi:10.1002/mus.880150415</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880150415</ArticleId><ArticleId IdType="pubmed">1565119</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y&#x2010;Q, Wang K&#x2010;R, Sun L, Wang Z. Clinical and electrophysiologic features of childhood Guillain&#x2010;Barre syndrome in Northeast China. J Formos Med Assoc. 2014;113(9):634&#x2010;639. doi:10.1016/j.jfma.2012.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2012.08.011</ArticleId><ArticleId IdType="pubmed">25103077</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy OC, Messacar K, Benson L, et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet (London, England). 2021;397(10271):334&#x2010;346. doi:10.1016/S0140-6736(20)32723-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32723-9</ArticleId><ArticleId IdType="pmc">PMC7909727</ArticleId><ArticleId IdType="pubmed">33357469</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert RD, Hawes IA, Ramachandran PS, et al. Pan&#x2010;viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med. 2019;25(11):1748&#x2010;1752. doi:10.1038/s41591-019-0613-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0613-1</ArticleId><ArticleId IdType="pmc">PMC6858576</ArticleId><ArticleId IdType="pubmed">31636453</ArticleId></ArticleIdList></Reference><Reference><Citation>Roodbol J, de Wit M&#x2010;CY, Aarsen FK, Catsman&#x2010;Berrevoets CE, Jacobs BC. Long&#x2010;term outcome of Guillain&#x2010;Barr&#xe9; syndrome in children. J Peripher Nerv Syst. 2014;19(2):121&#x2010;126. doi:10.1111/jns5.12068</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns5.12068</ArticleId><ArticleId IdType="pubmed">24863162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirolos A, Mark K, Shetty J, et al. Outcome of paediatric acute flaccid myelitis associated with enterovirus D68: a case series. Dev Med Child Neurol. 2018;61(3):376&#x2010;380. doi:10.1111/dmcn.14096</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/dmcn.14096</ArticleId><ArticleId IdType="pubmed">30417347</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JA, Messacar K, Yang ML, et al. Outcomes of Colorado children with acute flaccid myelitis at 1 year. Neurology. 2017;89(2):129&#x2010;137. doi:10.1212/WNL.0000000000004081</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004081</ArticleId><ArticleId IdType="pmc">PMC5501931</ArticleId><ArticleId IdType="pubmed">28615421</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes RAC, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain&#x2010;Barr&#xe9; syndrome. Cochrane Database Syst Rev. 2014;2014(9):CD002063. doi:10.1002/14651858.CD002063.pub6</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD002063.pub6</ArticleId><ArticleId IdType="pmc">PMC6781841</ArticleId><ArticleId IdType="pubmed">25238327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon AM, Clarke P, Tyler KL. Evaluating treatment efficacy in a mouse model of enterovirus D68&#x2010;associated paralytic myelitis. J Infect Dis. 2017;216(10):1245&#x2010;1253. doi:10.1093/infdis/jix468</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix468</ArticleId><ArticleId IdType="pmc">PMC5853295</ArticleId><ArticleId IdType="pubmed">28968718</ArticleId></ArticleIdList></Reference><Reference><Citation>Hopkins SE, Elrick MJ, Messacar K. Acute flaccid myelitis&#x2010;keys to diagnosis, questions about treatment, and future directions. JAMA Pediatr. 2018;173(2):117. doi:10.1001/jamapediatrics.2018.4896</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2018.4896</ArticleId><ArticleId IdType="pubmed">30500054</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Spence&#x2010;Davizon E, Osborne C, et al. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. Lancet Infect Dis. 2020;20(2):230&#x2010;239. doi:10.1016/S1473-3099(19)30632-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>